Table 1 Demographic factors, tumour and clinical trial type by study group
Intervention group ( n =59) | Control group ( n =58) | |
|---|---|---|
Gender | ||
Male : female | 1.1 : 1 | 1.4 : 1 |
Age in years | ||
Mean (s.d.) | 59.8 (11.6) | 57.4 (10.8) |
Marital status n (%) | ||
Living with spouse/partner | 53 (89.8) | 45 (81.8) |
Divorced | 3 (5.1) | 3 (5.5) |
Widowed | 1 (1.7) | 4 (7.3) |
Single | 2 (3.4) | 3 (5.5) |
Missing | 3 | |
Tumour type n (%) | ||
Breast | 7 (12.1%) | 5 (8.6%) |
Lung | 8 (13.8%) | 7 (12.1%) |
Upper GI | 7 (12.1%) | 10 (17.2%) |
Ovary | 7 (12.1%) | 5 (8.6%) |
Colorectal | 11 (19.0%) | 11 (19.0%) |
Other | 18 (31.0%) | 20 (34.5%) |
Drug Trial centre n (%) | ||
Centre 1 | 52 (88.1%) | 51 (87.9%) |
Centre 2 | 7 (11.9%) | 7 (12.1) |
Completed drug trial n (%) | ||
Yes | 17 (28.8%) | 20 (34.5%) |
No | 42 (71.2%) | 38 (65.5%) |
Days spent on drug trial | ||
Mean (s.d.) | 96.8 (68.2) | 97.8 (54.0) |
